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ABSTRACT
Modern mass spectrometers can accurately measure thousands of compounds in complex mixtures
over a given liquid chromatograph method, depending on desired outcome and method duration. This
stream of analytical chemistry has wide ranging application across food, pharma, environmental,
forensics, clinical and research. With consistent pressure on both the ruminant production and
product industries to face new and substantial challenges, liquid chromatography-mass spectrometry
(LC-MS) is an ideal tool to identify, detect and quantify markers of breeding, production and adaption
to support both research and industry to overcome these challenges. Herein, we provide a description
of the theoretical basis and framework for LC-MS as a rapidly developing technique and highlight its
application in measuring cattle and cattle product traits through protein quantitation with specific
focus on beta-casein proteoforms.

1.0 DESCRIPTION OF THEORETICAL BASIS AND FRAMEWORK FOR LIQUID CHROMATOGRAPHYMASS SPECTROMETRY (LC-MS)
1.1 An introduction to LC-MS
Liquid chromatography-mass spectrometry (LC-MS) is an analytical chemistry technique that permits
the time-resolved separation of compounds (e.g. proteins or peptides) in complex mixtures as well as
the simultaneous detection of specific compounds based on their elemental and structural properties.
Through carefully considered experimental design and controls, the technique permits accurate and
precise chemical measurements [1], for instance in order to quantify a specific compound (e.g. betacasein [β-CN] abundance in milk) or define a physical trait (e.g. a specific animal’s carcass quality [2]).
In principle, liquid chromatography (LC) involves exploiting the balance between a compound’s
propensity to interact with a stationary chemical structure and a competing mobile phase in order to
concentrate and resolve a compound in time. For peptides and proteins, the stationary phase typically
consists of chains of 18 carbons in length bound to a silica resin, called C18 (although other chemistries
such as C8 and C4 are also common); whereas, the mobile phase is typically a mixture of acidified
aqueous and organic solvent. Compounds are resolved by passing a gradient of the organic solvent
through a column of the stationary phase, thereby sequentially eluting each as their proclivity to bind
to the stationary phase is outweighed by their affinity for a specific concentration of the organic
solvent mobile phase. While LC has a well-characterised ability to resolve compounds in complex
matrices, the specificity afforded by this method can be limited in terms of quantitative purposes due
to co-elution of compounds. In this respect, LC is commonly coupled to mass spectrometry (MS) to
provide a combination of on-column concentration and separation with specific detection.
Mass spectrometry is an approach for the separation and detection of ionised gas-phase compounds
by their mass to charge ratios (m/z) [3]. When coupled to LC, the liquid sample exiting from the LC
column enters the instrument’s ion source where a combination of voltage, temperature and inert gas
are applied to the sample. These factors are used to aerosolize, guide and de-solvate the sample while
concomitantly imparting charge from the de-solvating liquid droplets to the compounds within during
the process [4]. The resulting gas phase ions can then be drawn into the mass spectrometer by means
of a voltage gradient. Therein, the ions are manipulated using electric or magnetic fields, voltage and
gas gradients for the purposes of focusing, transmission, isolation, — in some cases, chemical
reactions [5] — or fragmentation. In terms of fragmentation mechanisms, typically used approaches
rely on low or high energy collisional induced dissociation (CID) [6], employing argon, helium or
nitrogen as a collision gas, or fragmentation using electron-based gas dissociation approaches, which
rely on interactions between gas phase ions and electrons inducing fragmentation [7]. Electron-based
techniques include electron transfer dissociation (ETD) [8], electron capture dissociation (ECD) [9], hot
ECD (HECD) [10], electron-detachment dissociation (EDD) [11], electronic-excitation dissociation (EED)
[12] and electron induced dissociation (EID) [13]. The fragmentation approach applied will be
dependent on the analyte being measured and the type of analyser. Through combinations of these
gas phase manipulations, a selection of ionised compounds will transit the mass spectrometer to
ultimately reach the instrument’s detector and produce a response. This combination of ion source,
analyser and detector (or combined analyser/detector) are the key features of all mass spectrometers.
There are a range of LC-MS configurations used in modern analytical chemistry. In terms of LC, there
are two principal instrument types: high performance liquid chromatography and ultra-performance
liquid chromatography, with the latter offering enhancements in terms of speed, resolution and
sensitivity [14]. LC systems can also operate across several typical solvent flow rates, the lowest being
nano flow (~10–2500 nL/min) offering the highest sensitivity but lowest robustness and peak

resolution; the intermediate flow rates designated capillary flow (~1-10 µL/min) and micro flow (~10100 µL/min) offering a balance of robustness and sensitivity and moderate peak resolution; and,
analytical flow (~500-2000 µL/min) offering ultimate robustness and peak resolution but lowest
sensitivity [14]. The requirement of routine testing laboratories to produce reproducible results in a
timely fashion sees analytical flow often adopted, while research laboratories will typically use lower
flow rates due to their sensitivity gains.
In terms of MS systems, there are three principal commercial instrument configurations used in
quantitative analytical chemistry: low-resolution triple quadrupole (QqQ), high-resolution
quadrupole-quadrupole-time-of-flight (QqTOF) and orbital trapping instruments. Additionally, there
are a range of approaches to compound manipulation and detection afforded by these configurations
to specifically obtain the quantitative signal for a compound (or analyse data for the specific postacquisition extraction of a compound’s signal from complex data).
1.2 Data acquisition approaches
In terms of QqQ type instruments, the principle approach to specific compound detection is by
multiple reaction monitoring (MRM) [15]. This approach relies on the pre-selection of target precursor
ions and their specific product ions prior to data acquisition. In this respect, as a sample’s ions traverse
the mass spectrometer, the instrument’s first quadrupole analyser isolates the target precursor ions
(or, more precisely, regions of m/z space containing the target precursor ion and perhaps other nontarget precursor ions). These target ions are then fragmented by collision-induced dissociation in the
second quadrupole, which functions as a collision cell, to produce product ions. Subsequently,
individual target product ions are isolated (one at a time) in the third quadrupole to produce a
response at the detector that is specific for the combination of the target compound’s transition from
a precursor to a product ion.
Akin to MRM, high resolution MS2 (MS/MS) approaches rely on the reproducible detection of the
product ions that result from peptide fragmentation [16,17]. Here a compound of interest is isolated
and fragmented, after which a full spectrum of high-resolution product ions is collected using the TOF
or orbital trap. Specific product ion responses are then extracted from the resulting full spectrum
MS/MS data to computationally determine a quantitative measurement post-acquisition, rather than
on-the-fly. Due to its similarity to MRM, this method is referred to as MRM-high resolution (MRM-HR)
or parallel reaction monitoring (PRM).
The high resolution afforded by QqTOF and orbital trapping mass spectrometers may also be exploited
to resolve one compound from another, thereby providing requisite specificity (when combined with
a known LC elution time) to identify and quantify target peptides. Such an approach is referred to as
MS1 filtering [18].
High resolution MS analysis may also be directed towards intact protein detection and quantification
[19,20]. Specifically, when referring to the analysis of intact proteins by MS1, this approach is referred
to as “top-down intact” analysis [21]. Where these intact proteins are fragmented and sequenced is
referred to as “top-down sequencing” analysis [22].
1.3 New technologies
In addition to MRM, intact and MRM-HR, one additional quantitative acquisition approach — data
independent acquisition (DIA) — has gained vast popularity since its re-introduction at the HUPO
world congress in 2010 [23]. Nowadays, DIA in the proteomics field describes a substantial suit of
methods whereby fragment ion data for all detectable peptides is collected in such a fashion that, in

principle, specific quantitative data is obtainable for every detectable feature in each sample [24]. This
approach involves targeting a band of the mass-to-charge space (rather than a single ion worth, which
is about 0.7 Th), thereby co-isolating and co-fragmenting multiple ions to generate a high-resolution
convoluted product ion spectrum. In wide band DIA analysis, such as sequential window acquisition
of all theoretical ions (SWATH), this mass-to-charge band is stepped across the selected mass range
to enable chromatographic resolution of all detectable peptides’ product ions [23]. Alternatively, the
entire mass range can targeted to acquire data at low and high collision energy, to detect all co-eluting
fragments in a single scan in the style of MSE acquisition [25]. Akin to MRM-HR, specific product ions
are then computationally extracted post-acquisition to determine quantitative measurements.
Importantly, when combined with internal standards, this acquisition approach has shown promise
for absolute quantitation across the proteome [26,27]. See Zhang et al. for further reading [24].
Ion mobility spectrometry is a recently emerging technique in the proteomics field that is rapidly
growing in popularity, but yet to find its way to routine protein or peptide quantitation methods. Ion
mobility spectrometry makes use of collisional cross section [28] (the space around a compound in
which the center of another compound must occupy in order for a collision to occur) or dipole moment
[29] (the product of the magnitude of the charge and the distance between the centres of the positive
and negative charges of a polar compound) to resolve compounds in time. These resolved compounds
are then typically passed to the entrance of a mass spectrometer for conventional MRM, intact, MRMHR or DIA analysis, thereby enabling ion mobility as an added concentration and resolving coordinate
in additional to retention time, precursor and product ion masses. Such an advantage may lead to
improvements in both specificity and acquisition time and should be closely watched.
1.4 Considerations for quantitative LC-MS
Mass spectrometers are not inherently quantitative instruments. In order to produce quantitative
results using a matrix matched calibration curve-based approach, mass spectrometric assays should:
•
•
•
•

•
•

compare the responses of unknown samples to external synthetic calibration standards that
precisely mimic the target analyte;
calibration standards should be constituted in sample matrix that is devoid of the target
analyte but closely matches the target matrix (or matrix effects regularly quantified);
use the calibration standards to quantify the linear range of the compound’s response;
preferably include isotopically labelled internal standards, that precisely mimic the target
analyte in all but mass, in all standards and unknowns as early on in the sample processing as
possible to enable the correction of matrix and technical effects;
internal standards should also be at a concentration comparable to that expected in the
unknown samples; and,
quantify the upper and lower limits of quantitation (ULOQ and LLOQ), precision, accuracy and
recovery [1].

Such considerations, while not exhaustive, are fundamental to generating robust quantitative results
and should be followed wherever practicable.
In addition to the matrix matched external calibration, additional calibration strategies are available,
including: standard additional internal calibration and internal calibration by direct addition. The
former of these involves the preparation of a series of calibration samples where the matrix is the
sample itself. A calibration curve is then generated and the difference between the zero point on the
concentration axis and the intersection of the calibration line to the same axis is taken as the
concentration estimate [30]. The latter method, also commonly referred to as isotope dilution mass

spectrometry, typically involves comparing the response of a known amount of an internal spike of an
isotopologue to that of the native target compound in order to estimate the target compound
concentration by means of their ratio [31]. For further reading regarding reliable LC-MS
measurements see the Guide to achieving reliable quantitative LC-MS measurements [1].
2.0 APPLICATIONS IN CATTLE
2.1 LC-MS assays for cattle proteins
To date there have been relatively few published papers outlining the development of quantitative
LC-MS assays to measure proteins in cattle tissues or products. These studies have included the
assessment of beef gelatine origin [32], leather origin [33], meat quality [2] and low abundant serum
protein quantitation [34]. Where the determination of gelatine and leather origin and tenderness has
clear application in food quality/cultural requirement and fraud detection, the measurement of low
abundance serum proteins is desirable to measure animal traits via a protein proxy. Such traits may
include residual feed intake through growth factor measurement [35,36] or lactation transition
outcome through cytokine measurement [37,38].
In addition to the abovementioned cattle tissues and products, cow’s milk proteins have also been the
subject of substantial investigation by quantitative LC-MS.
2.2 Cows’ milk A1 and A2 β-CN proteoforms
Cows’ milk is a significant source of calories and nutrition for a segment of the population, with the
total milk production for 2017 estimated at 823,966 kt (approximately 749,060 ML) [39]. While a
critical source of calories, cows’ milk also poses a health risk to sub-populations in terms of allergy
(particularly in infants) and intolerance to milk components, namely protein and lactose. In this
respect, the prevalence of cows’ milk allergy by skin prick test is observed in the order of 0.2% to 2.5%
whereas serum IgE diagnosis ranges from 2% to 9% [40]. Global lactose intolerance is observed in the
order of 68%, with the maximum observed level at 100% for the South Korean population [41]. In
addition to these well-known milk-associated digestive issues, another potential and lesser-known
impact of cows’ milk on human health has been under investigation in the last few decades.
Substantial research effort has been placed in the investigation of the role that β-CN proteoforms may
play in human health and development, where the term proteoform refers to “all of the different
molecular forms in which the protein product of a single gene can be found, including changes due to
genetic variations, alternatively spliced RNA transcripts and post-translational modifications” [42]. The
drive for this research effort concerns the genetically recent appearance of the A1 β-CN protein
sequence variant and the inability of human digestive systems to have adapted to this dietary protein
within the same timeframe. Detail around this maladaptation primarily concerns a bioactive peptide
that is liberated from A1 β-CN during digestion but to a much lesser degree from A2 β-CN [43]. This
peptide, designated beta casomorphin-7 (BCM7), and the A1 protein in general, have been associated
with a slew of disease states [6,7,8,9,10]. For this reason, substantial selective breeding and genetic
testing programs have been undertaken to develop a cows’ milk product that contains only the A2
proteoform of β-CN [49]. Perhaps more importantly, the process of detecting β-CN genotypes in milkproducing cows was patented and is now licensed by the A2 Milk Company for use in the segregation
of animals (WO2003100074-A2), such that an A2 β-CN-only product — “A2 milk” — can be produced
and sold exclusively through the A2 Milk Company brand.
The production of A2-milk relies on the separation of herd animals such that A2 homozygous animals
are milked separately to A2 non-homozygous animals. While the science that supports such a practice

is sound, there are several circumstances that may lead to a final product reaching supermarket
shelves that is not free from other β-CN proteoforms. For example, inadvertent cross-contamination
through use of the same milking or freight equipment for A2 and other milk products; human error in
the dairy supply chain; and, purposeful adulteration of milk product (as A2 milk attracts a premium
wholesale price). In this regard, beyond the genetic separation of milk producing cows, the abundance
of A1 and A2 β-CN proteoforms should be measured and reported where claims of A2 protein-only
milk are made.
A1 and A2 β-CN proteoforms from cow are identical in primary sequence with the exception of a
Pro>His substitution at amino acid position 82 in A1 β-CN (also found in B, C, F and G proteoforms)
[50]. Such a relatively small difference in chemical composition renders several common analytical
techniques impractical, though not impossible [51], due to specificity or throughout, such as: ELISA
and SDS gel electrophoresis. Importantly, the detection and precise measurement of this minute
difference is ideally suited to mass spectrometric analysis; however, key experimental requirements
are essential to such measurement, as outlined above under section 1.4. Below we look at efforts to
detect and quantify A1 and A2 β-CN in cows’ milk and highlight their adherence to the above
quantitation requirements as well as their shortcomings, where relevant.
2.3 A1 and A2 β-CN proteoform quantitation by intact protein acquisition
Quantitative [52–54] and qualitative [55–58] mass spectrometric analysis of intact β-CN proteoforms
have been described for cows’ milk. The earliest report of a quantitative LC-MS approach described
the use of a C18-HPLC-QqTOF LC-MS to quantify β-CN A1, A2, B and C as a proportion of total caseins
— as measured by mid-infrared spectroscopy [52]. This analytical approach does not report the use
of internal standards to correct for matrix effects and instrument performance, or external standards
for measurement of each protein against like compounds in equivalent matrix. The authors make
assumptions that the mass spectrometric (or UV) response of each of the four casein proteins are
equivalent and that UV peaks do not contain more than one component. Though the methods may
have benefited from additional controls, this report of intact β-CN analysis was the first to
demonstrate detection and relative quantitation of intact β-CN proteoforms by LC-MS.
A more recent report of cow’s milk protein quantitation details the use of a C8-UPLC-QqTOF LC-MS to
quantify alpha-casein; β-CNs A1, A2, B, I; kappa-casein; alpha-lactalbumin; beta-lactoglobulin; bovine
serum albumin; and, a selection of their proteoforms resulting from phosphorylation [53]. The authors
improve upon the previous work and describe the use of a surrogate internal standard protein to
assess matrix effects, assess protein response linearity using calibration curves and quantify the matrix
effects from multiple cows’ milk samples. In terms of the calibration curves, the authors describe the
use of a single β-CN standard for measuring A1, A2, B and I β-CN, where the sum signal of these four
proteoforms is used to determine curve parameters over an eight-point series. In doing so, the authors
demonstrate the linear range for accurate quantitation. When measuring unknown milk samples, the
authors are then able to use the external standards for the purpose of validating protein identity by
mass and retention time matching. This approach allows profiling of various ruminant milk samples to
provide accurate relative quantitative changes between samples; however, this approach is unable to
provide absolute quantitation, primarily due to the absence of specific reference and internal
standards for A1/A2 β-CN.
The most recent and final report of intact β-CN quantitation goes to great effort to consider the
challenges of LC-MS quantitation of compounds in a complex food matrix [54]. Therein, the authors
use C4-UPLC-Q-orbital trap LC-MS to: generate external calibration curves that are adjusted for
standard purity; quantify matrix suppression; measure multiple proteoforms — up to two

lactosylation modifications per protein — and correct for signal suppression due to modification; and,
compensate for instrument performance using external quality control injections. Through their
thorough analysis of the β-CN standard, the authors also identify 31 β-CN proteoforms due to
unanticipated N- and C-terminal truncation. In this regard, eight proteoforms were found to be specific
for A2 β-CN, which appear to be summed for unmodified β-CN and glycosylated forms separately to
be converted into final concentration measurements. This work represents the most comprehensive
approach to β-CN quantitation in cows’ milk reported to date, but also highlights the challenges
pertaining to a lack of specific reference standards for each protein form, the measurement of multiple
proteoforms and the effects on competing ionisation on achievable dynamic range within a complex
food matrix.
Intact analysis and top down sequencing can aid in inferring proteoforms that arise from sequence
modifications and truncations; however, there remains the challenge of understanding and
quantifying the gas phase characteristics of each proteoform in order to obtain absolute
measurements — as demonstrated elegantly by Fuerer et al. for β-CN. This problem is pertinent to βCN from cow’s milk where it has been observed that up to eight proteoforms can be resolved by 2dimensional electrophoresis and LC-MS [54,59,60] and further, that β-CN is degraded as a function of
temperature and time [61]. An alternative approach is to use the peptide products of proteolytic
digestion to reduce several variable proteoforms down to a single peptide feature, thereby negating
the combinatorial problem of protein modifications and truncations (Figure 1). Where intact analysis
may benefit from simplified sample preparation and higher throughput, a proteolytic approach may
simplify measurement and data output but also benefit from access to more mature software for data
processing, interpretation, and reporting.
2.4 A1 and A2 β-CN proteoform quantitation by proteolytic digestion products
Given the challenges associated with unknown β-CN truncation and/or protein modifications in
determining protein abundance by intact mass, proteolytic sample processing and analysis may
provide a distinct advantage in addressing this combinatorial problem. In this respect, enzymatic
digestion of β-CN by trypsin (or other proteolytic enzymes) may be used to reduce the various
proteoforms to a single — or small number of peptides — that can be measured accurately (Figure 1).
Indeed, there is already public evidence regarding the tryptic digestion of β-CN, which shows that
there are four detectable peptides that carry the diagnostic amino acid at position 82
(http://www.peptideatlas.org/; Accession: ENSBTAP00000003409) [62]. Such a number is half that of
the proteoforms observed by intact mass analysis in a β-CN standard [54]. Yet, no research papers
have reported the quantitation of these four peptides in order to measure β-CN proteoforms;
although, there are several examples of A1 and A2 β-CN detection by proteolytic peptide analysis.
In 2017, Duarte-Vázquez, described the gel separation of A1 and A2 beta casein proteoforms by SDSPAGE analysis. The authors report the subsequent excision of the purported A1 and A2 β-CN bands
and digestion of their protein contents using the proteolytic enzyme thermolysin [49]. The extracted
peptides were then analysed by C18-nanoLC-orbital trap-Ion trap LC-MS/MS. Therein, the authors
make use of a spectral counting approach to quantify the amounts of the individual β-CN proteoforms
and express these values as mean relative abundance. Of note, the delta mass of the two casein
proteoforms is 40 Da, which may be challenging to separate and accurately excise from a typical SDSPAGE gel; however, no images of the gels in question are provided to make an objective assessment.
This challenging separation is made more obvious in the authors’ follow up paper that specifically
describes the use of SDS-PAGE separation and identical LC-MS/MS conditions to analyse the two β-CN
proteoforms [63]. The gel image provided shows minimal visual separation of the proteoforms.
Therein, the authors demonstrate the detection of one peptide specific for A1 β-CN but do not

describe whether the peptide is found in both excised regions of the gel. Furthermore, the peptide
sequence in question, PFPGPIHN, is not a specific product of thermolysin digestion at its N- or Ctermini, rendering it a non-specific product that is unsuitable for quantitation experiments.
Work published in 2019 details efforts towards absolute quantitation of a panel of 20 milk proteins
using bottom up analysis [64]. In this work the investigators use C18-HPLC-Linear Ion Trap LC-MS to
quantify milk protein target peptides using MRM. While the authors do not specifically quantify A1
and A2 proteoforms of β-CN, they do report the use of isotopically labelled internal standards in order
to account for matrix and technical variation as well as the determination of the upper and lower limits
of detection and LOQ. Furthermore, the investigators report the monitoring of instrument
performance through the interleaved analysis of a bovine serum albumin digest throughout the
acquisition batch.
In related work, Nguyen and co-workers describe the quantitation of BCM-5 and BCM-7 — β-CN
peptides that result from commercial milk processing and digestion in the gut [65]. Therein, the
authors describe the use of synthetic peptide calibration curves and isotopically labelled internal
standards combined with either MRM analysis on a C18-UPLC-QqQ LC-MS set up, or high resolution
MS1 analysis on a C18-HPLC-OrbitalTrap LC-MS system. The authors demonstrate their adherence to
the European Commission criteria (2002) for quantitative mass spectrometric detection, and in doing
so, provide an example of the requirements for A1 and A2 β-CN quantitation in cows’ milk.
Taken together, the published examples of A1 and A2 β-CN quantitation, and related studies,
demonstrate that A1 and A2 β-CN are detectable by both intact and proteolytic digestion approaches.
At present, none of the published works adhere to all key quantitative principals for A1/A2 β-CN
quantitation, including the use of heavy labelled internal standards and external calibration curves
(Supplementary table 1). What is also evident is that measurement of multiple proteoforms or
peptides is a requirement for accurate quantitation, due to inherent genetic variability and industrial
processing of cows’ milk. Furthermore, it is clear is that multiple skilled laboratories are working
towards a method for accurate quantitation of β-CN proteoforms and that, given access to reference
standards, publication of such a method may be anticipated in the near future.
3.0 CONCLUSIONS AND OUTLOOK
Liquid chromatography-mass spectrometry is a technique that has found wide adoption for the
measurement of proteins in complex mixtures in human clinical chemistry [66–70]. While there are
examples of studies that describe the identification of biomarkers for ruminant traits and their
transition to quantitative LC-MS assays (e.g. [2,71]), there remain limited papers demonstrating the
development of robust LC-MS quantitation of cattle protein biomarkers. Even so, where methods have
been developed, this technique has been able to provide information regarding cattle product origin,
quality and consumer safety. Moreover, it may be expected that investigators will continue to identify
and develop robust LC-MS assays to permit the accurate measurement or prediction of animal rearing
and production traits from known protein biomarkers [72].
With respect to β-CN quantitation in cows’ milk, the current literature demonstrates that there
remains a gap between aspiration and practical absolute quantitation. While ideally suited to LC-MS
protein quantitation, this application possesses a range of challenges, particularly in terms of the
management of the complex proteoforms or proteolytic products arising from the biological,
production and storage processes associated with cows’ milk production. Both intact and proteolytic
product analysis offer potential solutions to milk analysis. For instance, intact analysis offers the ability
to provide quality control through the screening of bulk product for anomalies as well as accurate

relative quantitation for reporting the proportions of A1 and A2 proteoforms in products or bulk milk.
Should absolute quantitation be a requirement, then analysts may look to measure proteolytic
digestion products, where there is ready access to synthetic peptide calibration standards as well as
isotopically labelled peptide internal standards. Both approaches have merit, depending on need, but
also have their challenges. Regardless, the development of a robust LC-MS assay for β-CN proteoforms
— or other informative bovine proteins — has the potential to provide both certainty for producers
as well as confidence for the consumer, and as such is a task worthy of further pursuit.
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Figure 1. The complexity of A1 and A2 β-CN gene variants and proteoforms. A: A1 and A2 β-CN gene
sequences have a single nucleotide difference that results in a proline or histidine during translation.
B: Eight example proteoforms of A1 β-CN protein are shown, demonstrating the impact of sequence
truncation and modifications (such as glycation, oxidation, phosphorylation, etc.). The A1 β-CN
protein may be expected to present as a similar set of eight proteoforms. In an ideal scenario, the
region of the protein containing the amino acid change can be proteolytically isolated using
enzymes. C: The complex set of A1 and A2 β-CN proteoforms is reduced to two peptides that can be
quantified to provide absolute concentration measurements when combined with synthetic
peptides and isotopically labelled standards.

